ELVN offering history
Every offering-related filing in Enliven Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 780 filings back to Apr 21, 2016.
| Date | Filing | What it means | |
|---|---|---|---|
| Jun 12, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 11, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 13, 2025 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Jun 16, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 13, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 13, 2025 | S-3MEF → | REGISTERED | S-3MEF registration — capacity to sell shares, not a sale yet |
| Apr 30, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 30, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 18, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Mar 19, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jul 6, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 3, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 23, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jan 23, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jan 23, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 15, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 14, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 13, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 8, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 1, 2021 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Mar 12, 2020 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Mar 11, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 10, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Mar 3, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 14, 2020 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
ELVN offering FAQ
When did ELVN last execute an offering?
Per SEC filings, Enliven Therapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2026-06-12. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did ELVN last announce or register an offering?
The most recent registration is a S-3ASR filed 2025-08-13. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.